Nuvation Bio Inc.
4.57USD
-0.1300 (-2.77%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on NUVB.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 32 | 83 | 42 | 13 | 5 | 3 | 6 | 1 |
| Cost of Revenue | — | — | — | 3 | 3 | 2 | 4 | 2 |
| Gross Profit | — | — | — | 10 | 2 | 1 | 1 | -1 |
| Operating Income | -51 | 4 | -34 | -56 | -64 | -59 | -54 | -48 |
| Net Income | -63 | 5 | -37 | -56 | -59 | -53 | -49 | -41 |
| EPS (Diluted) | -$0.18 | $0.01 | -$0.11 | -$0.16 | -$0.17 | -$0.16 | $0.00 | -$0.15 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)